Research progress of single-cell sequencing technology in liver diseases
10.3760/cma.j.cn501113-20210326-00140
- VernacularTitle:单细胞测序技术在肝脏疾病中的研究进展
- Author:
Sisi CHEN
1
;
Feng REN
;
Mei LIU
Author Information
1. 首都医科大学附属北京佑安医院肿瘤内科 北京肝病研究所，北京 100069
- Keywords:
Liver disease;
Single-cell sequencing;
Heterogeneity;
Pathogenesis
- From:
Chinese Journal of Hepatology
2023;31(2):198-201
- CountryChina
- Language:Chinese
-
Abstract:
Liver disease is one of the most burdensome diseases in the world. Therefore, new technologies are needed to study its pathogenesis in depth; however, because of its complex pathogenesis, there are relatively limited treatment options. Single-cell sequencing (SCS), as an emerging sequencing method, reflects the heterogeneity between cells by sequencing the genome, transcriptome, and epigenome of a single cell, thereby revealing the complex mechanisms of disease occurrence and development. The application of SCS in the study of liver diseases will enrich our understanding of the pathogenesis of liver diseases and provide a new direction for exploring the diagnosis and treatment. This article mainly reviews the research progress of SCS technology in liver diseases.
